/C O R R E C T I O N -- Medeon Biodesign, Inc./

Wednesday, March 29, 2017 General News
Email Print This Page Comment bookmark
Font : A-A+

In the news release, Medeon Biodesign Announces Investing in Panther Orthorpedic for Orthopedic Extremity Applications, issued 28-Mar-2017 by Medeon Biodesign,

Inc. over PR Newswire, we are advised by the company that its name in the headline should be "Panther Orthopedics" rather than "Panther Orthorpedic" as originally issued inadvertently. The complete, corrected release follows:

Medeon Biodesign
Announces Investing in Panther Orthopedics for Orthopedic Extremity Applications

TAIPEI, Taiwan, March 28, 2017 /PRNewswire/ -- Medeon Biodesign, Inc., a Taiwan medical device company, is pleased to announce that the Company led and successfully closed the Series A investment of Panther Orthopedics, Inc., a San Jose, CA start-up pioneering innovative dynamic fixation solutions for orthopedic extremity applications. 

The orthopedic extremity device market continues to expand rapidly, primarily due to procedure volume growth, lifestyle influences and favorable demographics. Nevertheless, the market need for better fixation products for both trauma and sports medicine in fracture fixation and joint stabilization applications is still under served. "Current options for fixation include cortical screw and suture button flexible fixation devices. However, many limitations associated with currently marketed products are not being addressed," said Dr. Kathryn Stecco, CEO and co-founder of Panther Orthopedics. "We have developed an innovative platform for dynamic extremity fixation, which we believe will provide continuous compression during the healing period while still allowing micromotion. The intuitive design of our solutions is easy to use and intended to eliminate the need for most second surgery removal, providing significant benefits for both the patients and the entire healthcare system."

"We are excited to lead the investment of Panther Orthopedics to address the long-standing need of better clinical fixation during the healing period for orthopedic extremity applications," said Dr. Yue-Teh Jang, CEO of Medeon Biodesign. "We are impressed with the team's extensive experience, profound knowledge of orthopedic applications and broad KOL networking. We are confident that the Panther Orthopedics' unique and innovative dynamic fixation solutions will be very welcome by the clinical community in the near future."

About Medeon Biodesign

Medeon Biodesign (TPEx: 6499) is a publicly traded company located in Taipei, Taiwan, and currently listed on Taipei Exchange. The company focuses on the development of medical devices for minimally invasive surgeries to treat diseases of sizable patient population, such as cardiovascular, peripheral vascular, orthopedic, neurosurgery, obesity, gastroenterology, hematology, nephrology, gynecology, urology, and plastic surgery. For more information, please visit www.medeonbio.com/en.

ContactsDr. Yi-Ju Chen+886.2.2881.6686 ir@medeonbio.com

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/medeon-biodesign-announces-investing-in-panther-orthorpedic-for-orthopedic-extremity-applications-300430173.html

SOURCE Medeon Biodesign, Inc.

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store